PCSA   $1.4  6.06% Market Closed After Close 1.49 6.43%

Processa Pharmaceuticals Inc
Total Cash 5.57M
totalCashPerShare 1.711
EBITDA -10.92M
Total Debt 118.83K
quickRatio 3.59
currentRatio 4.819
Total Revenue
debtToEquity 1.973
Revenue/Share
ROA -0.74391
ROE -1.34668
grossProfits
freeCashflow -4.52M
operatingCashflow -9.28M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -1.41M
forwardPE -0.6037736
floatShares 2.89M
sharesOutstanding 3.26M
sharesShort 61.94K
sharesShortPriorMonth 97.28K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.01%
Short Ratio help_outline 3.50%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 2.1
Price To Book help_outline 0.61
earningsQuarterlyGrowth
netIncomeToCommon -10.22M
trailingEps -5.25%
forwardEps -2.12%
enterpriseToEbitda 0.13
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.0 3Q 2024
institutionsCount 9
lastUpdated Oct. 16, 2024, 9:56 p.m.